• Consensus Rating: N/A
  • Consensus Price Target: $0.00
  • Forecasted Upside: -100.00%
  • Number of Analysts: 0
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$0.02
+0 (0.00%)
Get New Clarivate Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for CCC and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for CCC

Analyst Price Target is $0.00
▼ -100.00% Downside Potential
This price target is based on 0 analysts offering 12 month price targets for Clarivate in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a -100.00% upside from the last price of $0.02.

This chart shows the closing price for CCC for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is N/A

The current consensus among 0 investment analysts is to n/a stock in Clarivate. This N/A consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
6/16/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
9/14/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
12/13/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
3/12/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
6/10/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
9/8/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
11/7/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
12/7/2024

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
1/6/2021Morgan StanleyBoost TargetEqual Weight$29.00 ➝ $30.00
11/11/2020Morgan StanleyLower TargetEqual Weight$30.00 ➝ $29.00
10/30/2020Morgan StanleyLower TargetEqual Weight$32.00 ➝ $30.00
10/15/2020The Goldman Sachs GroupInitiated CoverageBuy$37.00
10/14/2020Morgan StanleyInitiated CoverageEqual Weight$32.00
10/2/2020BarclaysBoost TargetOverweight$26.00 ➝ $35.00
8/4/2020CitigroupBoost TargetBuy$28.00 ➝ $33.00
8/3/2020Royal Bank of CanadaBoost TargetOutperform$28.00 ➝ $32.00
7/31/2020B. RileyUpgradeNeutral ➝ Buy$24.00 ➝ $35.00
7/27/2020BarclaysInitiated CoverageOverweight$26.00
5/6/2020CitigroupBoost TargetBuy$24.00 ➝ $28.00
5/5/2020Royal Bank of CanadaReiterated RatingOutperform$25.00 ➝ $28.00
5/5/2020B. RileyBoost TargetNeutral$23.00 ➝ $24.00
4/19/2020The Goldman Sachs GroupUpgradeNeutral ➝ Buy
4/9/2020The Goldman Sachs GroupUpgradeNeutral ➝ Buy$22.00 ➝ $24.00
4/2/2020CitigroupUpgradeNeutral ➝ Buy$24.00
1/31/2020B. RileyDowngradeBuy ➝ Neutral$19.50 ➝ $23.00
1/20/2020Stifel NicolausUpgradeHold ➝ Buy$19.00 ➝ $22.00
12/11/2019Royal Bank of CanadaInitiated CoverageOutperform$21.00
12/11/2019The Goldman Sachs GroupInitiated CoverageNeutral$18.00
(Data available from 12/8/2019 forward)

News Sentiment Rating

0.56 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
5/11/2024
  • 0 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
6/10/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
7/10/2024
  • 0 very positive mentions
  • 7 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
8/9/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
9/8/2024
  • 1 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 1 very negative mentions
10/8/2024
  • 0 very positive mentions
  • 6 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
11/7/2024
  • 1 very positive mentions
  • 6 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
12/7/2024

Current Sentiment

  • 1 very positive mentions
  • 6 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.
Clarivate logo
Clarivate Plc, an information services and analytics company, provides structured information and analytics for discovery, protection, and commercialization of scientific research, innovations, and brands. It offers Web of Science products and services, such as Web of Science, InCites, Journal Citation Reports, EndNote, ScholarOne, Converis, Publons, and Kopernio to organizations that plan, fund, implement, and utilize research; and Life Sciences products, including Cortellis and Newport Integrity for pharmaceutical and biotechnology companies to support research, market intelligence, and competitive monitoring in connection with the development and commercialization of new drugs. The company also provides Derwent products, which include Derwent Innovation, Techstreet, and IP Professional Services that enables its customers to evaluate the novelty of potential new products, confirm freedom to operate with respect to their product design, help them secure patent protection, assess the competitive technology landscape, and ensure that their products comply with required industry standards; CompuMark products, such as trademark screening, searching, and watching products and services for businesses and law firms; and MarkMonitor products, which helps enterprises to establish, manage, optimize, and protect their online presence. It serves government and academic institutions, life science companies, and research and development corporations in the Americas, the Middle East, Africa, Europe, and the Asia Pacific. The company was formerly known as Clarivate Analytics Plc and changed its name to Clarivate Plc in May 2020. Clarivate Plc is headquartered in London, the United Kingdom.
Read More

Today's Range

Now: $0.02
Low: $0.02
High: $0.02

50 Day Range

MA: $29.06
Low: $27.85
High: $30.74

52 Week Range

Now: $0.02
Low: $15.00
High: $33.55

Volume

19,871 shs

Average Volume

1,238,000 shs

Market Capitalization

$12.12 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.53

Frequently Asked Questions

What sell-side analysts currently cover shares of Clarivate?

The following sell-side analysts have issued stock ratings on Clarivate in the last twelve months:
View the latest analyst ratings for CCC.

What is the current price target for Clarivate?

0 Wall Street analysts have set twelve-month price targets for Clarivate in the last year. has the lowest price target set, forecasting a price of $10,000,000.00 for Clarivate in the next year.
View the latest price targets for CCC.

What is the current consensus analyst rating for Clarivate?

Clarivate currently has from Wall Street analysts. The stock has a consensus analyst rating of "N/A."
View the latest ratings for CCC.

What other companies compete with Clarivate?

How do I contact Clarivate's investor relations team?

Clarivate's physical mailing address is 1500 SPRING GARDEN STREET, PHILADELPHIA PA, 19130. The industrial products company's listed phone number is 215-386-0100 and its investor relations email address is [email protected]. The official website for Clarivate is clarivate.com. Learn More about contacing Clarivate investor relations.